Financials

  • Market Capitalization 87.68 M
  • Employee 7
  • Founded 2018
  • CEO N/A
  • Website www.rallybio.com
  • Headquarter Delaware, United States
  • FIGI BBG011PFKF54
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.45
Relación precio/flujo de caja
36.01

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3981
ACRV
Acrivon Therapeutics, Inc. - Common Stock
2.12 USD-1.40%-5.78%+41.33%+59.40%90.85 M USD
3987
ICCC
ImmuCell Corporation - Common Stock
10.02 USD0.00%-0.30%-10.54%+59.30%91.00 M USD
4009
VRCA
Verrica Pharmaceuticals Inc. - Common Stock
5.07 USD+3.26%+3.47%-5.23%-15.78%87.10 M USD
4019
MAIA
MAIA Biotechnology, Inc. Common Stock
1.39 USD-1.42%0.00%+11.20%-33.17%84.55 M USD

Noticias